Gerber Kawasaki Wealth & Investment Management Atara Biotherapeutics, Inc. Transaction History

Gerber Kawasaki Wealth & Investment Management

$1.83 Billion
Q1 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 11, 2022	SELL	$14.7 - $19.89 $3,087 - $4,176	-210 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$11.99 - $17.9 $2,517 - $3,758	210 New	210 $3,000

Others Institutions Holding ATRA

# of Institutions

Shares Held

85M

Call Options Held

18.4K

Put Options Held

51.3K

Eco R1 Capital, LLC San Francisco, CA

10.2M
Shares

$76.5 Million
0.2% of portfolio
Redmile Group, LLC San Francisco, CA

9.26M
Shares

$69.7 Million
0.25% of portfolio
Black Rock Inc. New York, NY

6.83M
Shares

$51.4 Million
0.0% of portfolio
Bank Of America Corp Charlotte, NC

6.58M
Shares

$49.5 Million
0.0% of portfolio
Ken Griffin Citadel Advisors LLC | Chicago, Il

6.51M
Shares

$49 Million
0.0% of portfolio

View Full List

About Atara Biotherapeutics, Inc.

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $710M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

More about ATRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gerber Kawasaki Wealth & Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Gerber Kawasaki Wealth & Investment Management with notifications on news.

Account